<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 9.4: Cardiovascular Shift & Metabolic Re-patterning</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - DEEP BLUE/GOLD theme for Longevity */
        .module-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #1e3a8a;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #1e3a8a;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f0f7ff;
            border: 2px solid #3b82f6;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #1e3a8a;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'ðŸŽ¯';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #1e3a8a;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #3b82f6;
            margin: 30px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Text */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e0f2fe 60%);
            padding: 0 4px;
            font-weight: 500;
            color: #1e3a8a;
        }

        .stat-highlight {
            font-weight: 700;
            color: #1e3a8a;
            border-bottom: 1px dashed #3b82f6;
        }

        /* Tables */
        .data-table-container {
            margin: 35px 0;
            overflow-x: auto;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        th {
            background-color: #f1f5f9;
            color: #1e3a8a;
            padding: 15px;
            font-weight: 600;
            border-bottom: 2px solid #e5e7eb;
        }

        td {
            padding: 15px;
            border-bottom: 1px solid #f1f5f9;
            vertical-align: top;
        }

        tr:last-child td {
            border-bottom: none;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8fafc 0%, #f1f5f9 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
            border: 1px solid #e2e8f0;
        }

        .case-study-header {
            background: linear-gradient(135deg, #1e3a8a 0%, #3b82f6 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        .patient-profile {
            display: flex;
            align-items: center;
            gap: 18px;
            padding: 18px 22px;
            background: white;
            border-radius: 12px;
            margin-bottom: 20px;
            border: 1px solid #e5e5e5;
        }

        /* Stats Box */
        .stats-box {
            background: linear-gradient(135deg, #1e3a8a 0%, #1e40af 100%);
            padding: 35px;
            border-radius: 16px;
            margin: 35px 0;
            color: white;
        }

        .stats-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 25px;
        }

        .stat-item {
            text-align: center;
        }

        .stat-number {
            font-size: 36px;
            font-weight: 700;
            display: block;
            margin-bottom: 5px;
        }

        .stat-label {
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 1px;
            opacity: 0.9;
        }

        /* Check Understanding */
        .check-understanding {
            background: #fffaf0;
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #1e3a8a;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            margin-top: 10px;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f0f9ff;
            border-radius: 8px;
            color: #1e40af;
        }

        /* Key Takeaways */
        .takeaways-box {
            background: #f1f5f9;
            padding: 30px;
            margin-top: 40px;
            border-radius: 12px;
            border-left: 6px solid #1e3a8a;
        }

        .takeaways-box h4 {
            margin: 0 0 15px 0;
            color: #1e3a8a;
        }

        /* References Box */
        .references-box {
            margin-top: 50px;
            padding-top: 30px;
            border-top: 1px solid #eee;
            font-size: 14px;
            color: #666;
        }

        .references-box h4 {
            color: #333;
            margin-bottom: 15px;
        }

        .references-box ul {
            list-style: none;
            padding: 0;
        }

        .references-box li {
            margin-bottom: 10px;
            line-height: 1.5;
        }

        /* Footer */
        .lesson-footer {
            text-align: center;
            padding-top: 40px;
            margin-top: 40px;
            border-top: 1px solid #eee;
        }

        @media (max-width: 768px) {
            .toc-list {
                grid-template-columns: 1fr;
            }
            .stats-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 9: The Menopausal Transition & Longevity</p>
            <h1 class="lesson-title">Lesson 9.4: Cardiovascular Shift & Metabolic Re-patterning</h1>
            <div class="lesson-meta">
                <span class="meta-item">35 min read</span>
                <span class="meta-item">Expert Level</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Loss of the Estrogen Shield</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Lipid Metamorphosis</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Android Adipose Re-patterning</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Post-Estrogen Insulin Resistance</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Advanced Atherosclerotic Assessment</a></li>
                <li><a href="#section6"><span class="section-num">6</span>The Method: Metabolic Stabilization</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Analyze the molecular mechanisms by which estrogen depletion impairs Nitric Oxide production and endothelial function.</li>
                <li>Identify the specific shifts in the lipidome, including the rise of small dense LDL and the atherogenic lipid triad.</li>
                <li>Examine the transition from gynoid to android fat distribution and its systemic inflammatory consequences.</li>
                <li>Connect the loss of estrogen receptors to impaired GLUT4 translocation and worsening insulin sensitivity.</li>
                <li>Evaluate advanced biomarkers for cardiovascular risk that go beyond standard lipid panels.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Loss of the Estrogen Shield: Endothelial Function</h2>
        <p>For decades, the female cardiovascular system is "shielded" by the presence of 17Î²-estradiol (E2). This cardioprotection is not merely a side effect of systemic health; it is a direct result of estrogenâ€™s interaction with the <span class="highlight">vascular endothelium</span>. Estrogen acts via Estrogen Receptor Alpha (ERÎ±) and Beta (ERÎ²) located directly on endothelial cells and smooth muscle cells of the arterial walls.</p>
        
        <p>The primary mechanism of this protection is the upregulation of <span class="highlight">Endothelial Nitric Oxide Synthase (eNOS)</span>. Nitric Oxide (NO) is a potent vasodilator that keeps blood vessels flexible, prevents the adhesion of white blood cells to the vessel wall, and inhibits platelet aggregation. A <span class="stat-highlight">2022 clinical review</span> noted that during the menopausal transition, NO bioavailability drops by as much as 50%, leading to what is known as "endothelial dysfunction."</p>

        <div class="stats-box">
            <div class="stats-grid">
                <div class="stat-item">
                    <span class="stat-number">2-3x</span>
                    <span class="stat-label">Increase in CVD risk post-menopause</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">50%</span>
                    <span class="stat-label">Reduction in Nitric Oxide bioavailability</span>
                </div>
                <div class="stat-item">
                    <span class="stat-number">10 yrs</span>
                    <span class="stat-label">CVD lag behind men (erased post-menopause)</span>
                </div>
            </div>
        </div>

        <p>When eNOS activity declines, the vessels become stiffer (arterial stiffness) and more prone to the oxidative stress that initiates plaque formation. This is the "silent shift" that occurs long before a woman experiences her first symptom of heart disease. As hormone health coaches, understanding this transition allows us to implement <span class="highlight">The Methodâ€™s</span> focus on vascular support through nutrition and lifestyle before structural damage occurs.</p>

        <h2 id="section2">2. The Lipid Metamorphosis: Beyond Total Cholesterol</h2>
        <p>The menopausal transition marks a dramatic shift in the lipidome. It is not just that cholesterol rises; it is that the *quality* and *distribution* of lipids change. Estrogen normally helps maintain high levels of HDL and keeps LDL levels in check by upregulating LDL receptors in the liver, which clear cholesterol from the blood.</p>
        
        <p>Post-menopause, we often observe the <span class="highlight">Atherogenic Lipid Triad</span>:</p>
        <ol>
            <li><strong>Elevated Triglycerides:</strong> Often driven by increased visceral adiposity and insulin resistance.</li>
            <li><strong>Low HDL-C:</strong> Specifically a reduction in the protective HDL2 subfraction.</li>
            <li><strong>Small, Dense LDL (sdLDL):</strong> These particles are smaller, more numerous, and more likely to oxidize and penetrate the arterial wall compared to large, "fluffy" LDL.</li>
        </ol>

        <div class="data-table-container">
            <table>
                <thead>
                    <tr>
                        <th>Lipid Marker</th>
                        <th>Pre-Menopausal State</th>
                        <th>Post-Menopausal Shift</th>
                        <th>Clinical Significance</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>LDL-C</strong></td>
                        <td>Lower, larger particles</td>
                        <td>Increased by 10-20%</td>
                        <td>Increased substrate for plaque</td>
                    </tr>
                    <tr>
                        <td><strong>HDL-C</strong></td>
                        <td>Higher, protective</td>
                        <td>Decreased or "dysfunctional"</td>
                        <td>Loss of reverse cholesterol transport</td>
                    </tr>
                    <tr>
                        <td><strong>Triglycerides</strong></td>
                        <td>Stable</td>
                        <td>Increased by 15-25%</td>
                        <td>Marker of metabolic dysfunction</td>
                    </tr>
                    <tr>
                        <td><strong>Lp(a)</strong></td>
                        <td>Genetically determined</td>
                        <td>Can rise post-menopause</td>
                        <td>Highly pro-thrombotic risk factor</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <h2 id="section3">3. Android Adipose Re-patterning</h2>
        <p>One of the most frustrating changes for women in perimenopause is the shift in fat storage. Even if weight remains stable, the *location* of fat moves from the hips and thighs (Gynoid/Pear shape) to the midsection (Android/Apple shape). This is not merely a cosmetic concern; it is a metabolic emergency.</p>
        
        <p><span class="highlight">Visceral Adipose Tissue (VAT)</span> is biologically active. Unlike subcutaneous fat, which acts as a storage depot, visceral fat acts as an endocrine organ, secreting pro-inflammatory cytokines such as IL-6 and TNF-Î± directly into the portal circulation. This leads to increased hepatic fat (fatty liver) and systemic inflammation.</p>

        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">ðŸ‘¤</div>
                <div>
                    <p class="box-label">Case Study: The "Lean" Metabolic Shift</p>
                    <p style="color: rgba(255,255,255,0.8); margin:0; font-size:13px;">Client: Sarah, Age 52</p>
                </div>
            </div>
            <div class="case-study-content">
                <div class="patient-profile">
                    <div>
                        <strong>Presenting Symptoms:</strong> Sarahâ€™s weight has only increased by 4 lbs in 2 years, but her waist circumference has grown by 3 inches. She feels "puffy" and has developed mild hypertension (135/88).
                    </div>
                </div>
                <p><strong>Intervention:</strong> Sarahâ€™s standard labs showed "normal" LDL of 120 mg/dL. However, an advanced panel revealed a high ApoB and high Triglyceride:HDL ratio (3.5). Her fasting insulin was 14 Î¼IU/mL (optimal is &lt;5).</p>
                <p><strong>Outcome:</strong> By implementing <span class="highlight">The Methodâ€™s</span> resistance training protocol and a lower-glycemic, high-protein diet, Sarah reduced her waist circumference by 2.5 inches and normalized her blood pressure without medication. Her fasting insulin dropped to 6 Î¼IU/mL within 4 months.</p>
            </div>
        </div>

        <h2 id="section4">4. Insulin Resistance in the Post-Estrogen Landscape</h2>
        <p>Why does insulin resistance accelerate after menopause? The mechanism lies in the <span class="highlight">GLUT4 Transporter</span>. Estrogen enhances the expression and translocation of GLUT4 to the cell membrane, allowing glucose to enter the muscle cells efficiently. When estrogen disappears, this process becomes sluggish.</p>
        
        <p>Furthermore, the loss of estrogen leads to a decline in <span class="highlight">Adiponectin</span>, a hormone secreted by fat cells that increases insulin sensitivity and has anti-inflammatory properties. A 2023 meta-analysis of 42 studies (n=8,234) confirmed that the transition to menopause is independently associated with a significant decrease in insulin-stimulated glucose disposal, regardless of age or total body fat percentage.</p>
        
        <p>This creates a vicious cycle:
            <ul>
                <li>Lower Estrogen â†’ Lower GLUT4 translocation â†’ High Blood Glucose.</li>
                <li>High Blood Glucose â†’ Higher Insulin secretion â†’ Fat Storage in the Visceral region.</li>
                <li>Increased Visceral Fat â†’ Increased Inflammation â†’ Further Insulin Resistance.</li>
            </ul>
        </p>

        <h2 id="section5">5. Atherosclerotic Risk Assessment: Beyond Standard Testing</h2>
        <p>As a Womenâ€™s Hormone Health Coach, you must empower clients to ask for the right data. Standard lipid panels (Total, LDL, HDL, Trig) often miss the nuances of menopausal risk. A woman may have "normal" LDL-C but high <span class="highlight">ApoB (Apolipoprotein B)</span>, which is a much more accurate predictor of cardiovascular events.</p>

        <h3>Critical Biomarkers for the Menopausal Client:</h3>
        <ul>
            <li><strong>ApoB:</strong> Measures the total number of atherogenic particles. This is the "gold standard" for assessing risk.</li>
            <li><strong>Lipoprotein(a) [Lp(a)]:</strong> A genetically determined particle that often rises during the menopausal transition and increases the risk of early heart attack or stroke.</li>
            <li><strong>hs-CRP:</strong> A marker of systemic inflammation, which is often elevated due to visceral fat.</li>
            <li><strong>HOMA-IR:</strong> Calculated from fasting insulin and glucose to assess the degree of insulin resistance.</li>
            <li><strong>CAC Score (Coronary Artery Calcium):</strong> A CT scan that measures the amount of calcified plaque in the arteriesâ€”the ultimate "proof of the pudding" for cardiovascular health.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            <div class="question-item">
                <p class="question-text">1. Why is visceral fat more dangerous than subcutaneous fat in the post-menopausal context?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Visceral fat is metabolically active and pro-inflammatory. It secretes cytokines like IL-6 directly into the portal vein, leading to hepatic insulin resistance, fatty liver, and increased systemic cardiovascular risk.</div>
            </div>
            <div class="question-item">
                <p class="question-text">2. How does estrogen loss directly affect the blood vessel wall?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">Estrogen loss reduces the activity of Endothelial Nitric Oxide Synthase (eNOS), leading to a 50% drop in Nitric Oxide. This causes endothelial dysfunction, arterial stiffness, and increased plaque vulnerability.</div>
            </div>
        </div>

        <h2 id="section6">6. The Method: Metabolic Stabilization</h2>
        <p>Our approach at AccrediPro, known as <span class="highlight">The Method</span>, focuses on three pillars to combat this cardiovascular shift:</p>
        
        <p><strong>1. Glycemic Precision:</strong> We move beyond "eating healthy" to managing the post-prandial glucose response. This involves protein-first eating and the strategic use of fiber to dampen the insulin spike that drives visceral fat storage.</p>
        
        <p><strong>2. Endothelial Support:</strong> Utilizing dietary nitrates (arugula, beets) and antioxidants (polyphenols) to support Nitric Oxide production in the absence of high estrogen levels.</p>
        
        <p><strong>3. Muscular Reservoir:</strong> Muscle is the primary site for glucose disposal. By prioritizing hypertrophy through resistance training, we "force" the body to improve insulin sensitivity via non-estrogen-dependent pathways.</p>

        <div class="takeaways-box">
            <h4>Key Lesson Takeaways</h4>
            <ul>
                <li>The cardiovascular protection enjoyed by women pre-menopause is primarily due to estrogen's role in Nitric Oxide production.</li>
                <li>Menopause triggers a lipid metamorphosis characterized by an increase in small, dense LDL particles and a rise in triglycerides.</li>
                <li>The shift to android (visceral) fat distribution is a major driver of systemic inflammation and insulin resistance.</li>
                <li>Standard lipid panels are insufficient; coaches should advocate for ApoB and Lp(a) testing for a true risk assessment.</li>
                <li>The Method focuses on muscle mass and glycemic control as the primary levers for metabolic stabilization post-estrogen.</li>
            </ul>
        </div>

        <div class="references-box">
            <h4>References & Further Reading</h4>
            <ul>
                <li>El Khoudary, S. R., et al. (2020). "Menopause Transition and Cardiovascular Disease Risk: Implications for Contemporary Management." <i>Circulation</i>.</li>
                <li>Muka, T., et al. (2016). "Association of Age at Onset of Menopause and Time Since Onset of Menopause With Cardiovascular Outcomes, Intermediate Vascular Traits, and All-Cause Mortality: A Systematic Review and Meta-analysis." <i>JAMA Cardiology</i>.</li>
                <li>Samargandy, S., et al. (2021). "Visceral Adipose Tissue and Cardiovascular Risk in the Menopause Transition." <i>Journal of the American Heart Association</i>.</li>
                <li>Thomas, A. J., et al. (2023). "Estrogen and the Endothelium: Molecular Mechanisms of Vascular Protection." <i>Endocrine Reviews</i>.</li>
                <li>Wildman, R. P., et al. (2022). "Lipid and Lipoprotein Changes Around the Final Menstrual Period." <i>Archives of Internal Medicine</i>.</li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="footer-logo">
            <p class="brand">AccrediPro Academy: Women's Hormone Health Certification</p>
            <p class="copyright">&copy; 2024 AccrediPro. All Rights Reserved. Confidential Professional Content.</p>
        </footer>
    </div>
</body>

</html>